Correlation Between Aridis Pharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Virax Biolabs.
Diversification Opportunities for Aridis Pharmaceuticals and Virax Biolabs
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aridis and Virax is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Aridis Pharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Aridis Pharmaceuticals is expected to under-perform the Virax Biolabs. In addition to that, Aridis Pharmaceuticals is 1.11 times more volatile than Virax Biolabs Group. It trades about -0.02 of its total potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.01 per unit of volatility. If you would invest 1,090 in Virax Biolabs Group on September 3, 2024 and sell it today you would lose (893.00) from holding Virax Biolabs Group or give up 81.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 30.3% |
Values | Daily Returns |
Aridis Pharmaceuticals vs. Virax Biolabs Group
Performance |
Timeline |
Aridis Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virax Biolabs Group |
Aridis Pharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aridis Pharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Aridis Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.Aridis Pharmaceuticals vs. Akari Therapeutics PLC | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. ABVC Biopharma | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
Virax Biolabs vs. DiaMedica Therapeutics | Virax Biolabs vs. Lyra Therapeutics | Virax Biolabs vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |